Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2005
10/06/2005US20050221366 testing ambient air for bio-contaminants; interior air quality; reporting system that can collect and report data on airborne pathogens as well as mold, fungi and other airborne biological contaminates
10/06/2005US20050221365 Polymerase chain reaction using metallic glass-coated microwire
10/06/2005US20050221363 Universal shotgun assay
10/06/2005US20050221362 Method for immobilizing nucleic acid and method for manufacturing biosensor using the same method
10/06/2005US20050221361 Encoded carrier and a method of monitoring an encoded carrier
10/06/2005US20050221360 Method for purifying microbeads
10/06/2005US20050221359 Cospeptin, cosmedin and their uses
10/06/2005US20050221358 Pressure chamber clamp mechanism
10/06/2005US20050221357 Normalization of gene expression data
10/06/2005US20050221356 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof
10/06/2005US20050221355 cDNA for human methylenetetrahydrofolate reductase and uses thereof
10/06/2005US20050221354 Nucleic acid arrays for monitoring expression profiles of drug target genes
10/06/2005US20050221353 Data processing and display method for gene expression analysis system and gene expression analysis system
10/06/2005US20050221352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/06/2005US20050221351 Methods and devices for microarray image analysis
10/06/2005US20050221350 Method for identifying immunoreactive peptides
10/06/2005US20050221349 based on the use of "two-component conjugate" systems comprising a catalytic label and a substrate label; reagent kit; antibodies labelled with two DNA substrates and a DNA-dependent enzyme that modifies the DNA in a detectable process can be used to detect antigen for example
10/06/2005US20050221348 Drug screening; using a collection of proteinaceous biomarkers ("AD biomarkers) which can be measured in peripheral biological fluid samples to aid in the diagnosis of neurodegenerative disorders
10/06/2005US20050221346 May be used to detect the presence of a cancer or to evaluate the prognosis of a known disease
10/06/2005US20050221344 Interferon-Like molecules and uses thereof
10/06/2005US20050221343 Self-assembling split-fluorescent protein systems
10/06/2005US20050221342 Nucleic acids and polypeptides
10/06/2005US20050221341 Sequence-based karyotyping
10/06/2005US20050221340 Computer-directed assembly of a polynucleotide encoding a target polypetide
10/06/2005US20050221339 Compartmentalised screening by microfluidic control
10/06/2005US20050221338 Novel fluorescent protein and gene encoding the same
10/06/2005US20050221337 Microarrays and microspheres comprising oligosaccharides, complex carbohydrates or glycoproteins
10/06/2005US20050221336 Mutations in capillary morphogenesis gene-2 (CMG-2) and use thereof
10/06/2005US20050221335 Reporter gene
10/06/2005US20050221334 Tape stripping methods for analysis of skin disease and pathological skin state
10/06/2005US20050221333 Microfluidic apparatus, systems, and methods for performing molecular reactions
10/06/2005US20050221332 Corticotropin releasing hormone (CRH); pro-opiomelanocortin (POMC); distinguishing bovines having a CRH gene polymorphism; isolating a genomic DNA sample; amplifying; detecting a polymorphism present in the CRH gene at position 22
10/06/2005US20050221330 Glial cell line-derived neurotrophic factor (GDNF); nervous system disorders, autonomic nervous system, shingles, asthma, irritable bowel, inflammatory bowel, constipation, headache, arthritis, spinal cord injury, chronic back pain, hypertension, mucositis, diabetes, fibromyalgia, and wound healing
10/06/2005US20050221329 Use of fluorescent molecular beacons in the detection of methylated nucleic acid
10/06/2005US20050221328 Inhibitors of inflammatory gene activity and cholesterol biosynthesis
10/06/2005US20050221327 Detecting integrin alpha 10 chain expressing mesenchymal stem cells (MSC) for use in tissue repair and/or regeneration
10/06/2005US20050221326 Oligonucleotides antibodies and kits including same for treating prostate cancer and determining predisposition thereto
10/06/2005US20050221325 Detection of secreted polypeptides
10/06/2005US20050221324 Genotoxicity analysis
10/06/2005US20050221322 Multiple closed nucleus breeding for swine production
10/06/2005US20050221321 Method of detecting rheumatoid arthritis by detecting overexpression of wnt
10/06/2005US20050221320 Method
10/06/2005US20050221319 Use of capturing probes for identifying nucleic acids
10/06/2005US20050221318 Building block forming a c-c bond upon reaction
10/06/2005US20050221317 Use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
10/06/2005US20050221316 Method for synthesising templated molecules
10/06/2005US20050221315 Nucleic acid probes, their synthesis and use
10/06/2005US20050221314 Method and device for determination of tissue specificity of free floating dna in bodily fluids
10/06/2005US20050221313 Methods of identifying gene expression products resultant from alternative splicing and methods of diagnosing and treating disorders associated therewith
10/06/2005US20050221312 Selective amplification of a template molecule, especially a nucleic acid
10/06/2005US20050221311 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and used thereof
10/06/2005US20050221310 Methods for enhancing gene expression analysis
10/06/2005US20050221309 Method for the diagnosis of lymphoproliferative diseases
10/06/2005US20050221306 Detection of predisposition to osteoporosis
10/06/2005US20050221305 Antigen panels and methods of using the same
10/06/2005US20050221304 Modified random primers for probe labeling
10/06/2005US20050221303 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/06/2005US20050221301 Reference clones and sequences for non-subtype B isolates of human immunodeficiency virus type 1
10/06/2005US20050221300 Diagnostic assays for parvovirus B19
10/06/2005US20050221298 Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease
10/06/2005US20050221297 Diagnostic reagent for hepatitis C virus infection
10/06/2005US20050221296 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay; antigenic peptides of HCV immobilized on solid substrate
10/06/2005US20050221294 Inhibitors of HIV membrane fusion
10/06/2005US20050221293 Isolated nucleic acid molecule comprising the sequence of a DNA virus microRNA; Epstein barr virus; inhibiting microRNP activity in a cell
10/06/2005US20050221291 Dc-sign isoforms, related compositions and methods for their use in disease therapy
10/06/2005US20050221290 Identification and validation of novel targets for agrochemicals
10/06/2005US20050221289 Altering viral tropism
10/06/2005US20050221288 Variant tat proteins and methods for use thereof
10/06/2005US20050221287 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
10/06/2005US20050221286 Protease assay for therapeutic drug monitoring
10/06/2005US20050221284 Heteropolymer complexes and methods for their use
10/06/2005US20050221281 Self-contained microfluidic biochip and apparatus
10/06/2005US20050221280 Profiling chemical compounds to improve drug safety and efficacy at an early stage in drug development
10/06/2005US20050221279 Method for creating chemical sensors using contact-based microdispensing technology
10/06/2005US20050221276 Sensor system
10/06/2005US20050221275 Hepatocyte free uptake assays
10/06/2005US20050221272 Obtaining a cell that expresses a fusion protein containing a glutamine-rich polypeptide and a fluorescent polypeptide; exposing the cell to a compound; incubating the cell, measuring second fluorescence emission
10/06/2005US20050221271 Substrates, devices, and methods for cellular assays
10/06/2005US20050221270 Process for identifying and treating cells types within a living organism
10/06/2005US20050220854 Apparatus and method for transdermal delivery of influenza vaccine
10/06/2005US20050220819 Novel binding epitopes for helicobacter pylori and use thereof
10/06/2005US20050220816 Mutant viral nucleic acids and vaccine containing same
10/06/2005US20050220812 Screening process
10/06/2005US20050220811 Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/06/2005US20050220798 Cancer-linked gene as target for chemotherapy
10/06/2005US20050220788 Use of molecules which interact with the haptoglobin receptor ligand binding
10/06/2005US20050220769 Novel endophytic fungi and methods of use
10/06/2005US20050220762 Modified human interferon polypeptides and their uses
10/06/2005US20050220712 Method for determining mucosal neutrophil counts in neutropenia patents
10/06/2005US20050220710 Overfeeding methods for determining therapeutic strategies and/or targets for obesity therapeutics
10/06/2005US20050220677 Evidence collection holder for sample automation
10/06/2005US20050220342 Luminescent intensity analysis method and apparatus
10/06/2005US20050217599 Saddlebox pet carrier product
10/06/2005DE102004013697A1 Verfahren zur Identifizierung von gegen Geruchskeime antibakteriell wirksamen Substanzen und von Substanzen, die im axillaren Bereich präbiotisch wirksam sind A method for identifying germs against odor antibacterially active substances and substances which are effective in the axillary region with a probiotic
10/06/2005DE10103954B4 Verfahren zur Analyse von Makromolekülen A process for the analysis of macromolecules
10/06/2005CA2563886A1 Compositions and methods for controlling insects related to the octopamine receptor
10/06/2005CA2561511A1 Method of monitoring microbe causing infectious disease of experimental animal
10/06/2005CA2561502A1 Marker gene for arthrorheumatism test
10/06/2005CA2561495A1 Truncated dance, dance complex and method of using these
1 ... 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 ... 3003